Chemotherapy induced side effects Side effects cancer therapy
Conditions
Interventions
Patients will be randomized to the intervention group, using the eChemoCoach in addition to standard of care monitoring to manage side effects, or to the control group who receive standard of care mon
Sponsors
Noordwest Ziekenhuisgroep
Eligibility
Age
16 Years to 64 Years
Inclusion criteria
Inclusion criteria: Starting (neo)adjuvant treatment with chemotherapy for breast cancer - Being able to read or get help from a relative in case of illiteracy - Age = 18 years - WHO PS =1 - Capable of using the EHP (incl. DigiD login) - Did not receive a form of chemotherapy in the past
Exclusion criteria
Exclusion criteria: - Participation in a trial with an investigational product - Patients that already started with their chemotherapy cycle
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The occurrence of any non-hematological side effect grade =3 during the (neo)adjuvant treatment, presented as numbers with percentages for patients in both study groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Patterns of toxicity: time to first occurrence of grade =3 and grade 2 toxicity 2. Relative Dose Intensity (RDI) – target =85% 3. Health-related quality of life (QLQ-C30s) 4. Patient anxiety (HADS) 5. Patient stress (Distress thermometer) 6. Patient empowerment (PAM-12) 7. Unplanned out-patient visits and hospital admissions 8. Optimization of eChemoCoach questionnaires 9a. Usability of eChemoCoach (patients) 9b. Usability of EHR dashboard (caregivers) | — |
Countries
Netherlands
Contacts
Public ContactM.M.C. Hanrath-Komen
Noordwest Ziekenhuisgroep
Outcome results
None listed